Clinical Trial Update: A Blind, Randomized and Controlled Study of Live Attenuated Varicella Vaccines [Phase 3]

View source ↗

Summary

A blind, randomized, controlled Phase 3 trial of a live attenuated varicella vaccine developed by Sinovac Dalian Vaccine Technology Co., Ltd. has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicella

Drugs mentioned

• Live attenuated varicella vaccine (Sinovac Dalian) (varicella vaccine, live attenuated)

Snippet

Sponsor: Sinovac (Dalian) Vaccine Technology Co., Ltd. | Conditions: Varicella | Phase 3 | Status: COMPLETED